Literature DB >> 12767841

Effect of central venous catheter type on infections: a prospective clinical trial.

B Richards1, W Chaboyer, T Bladen, P J Schluter.   

Abstract

This study reports on a block clinical trial of two types of central venous catheters (CVCS): antiseptic-impregnated catheters (AIC) and non-impregnated catheters (non-AIC), on catheter tip colonization and bacteraemia. In total, 500 catheters were inserted in 390 patients over the 18 month study period, 260 (52.0%) AIC and 240 (48.0%) non-AIC. Of these, 460 (92.0%) tips (237 AIC and 223 non-AIC) were collected. While significantly fewer AIC, 14 (5.9%), than non-AIC, 30 (13.5%), catheters were colonized (P<0.01), there was no difference in the rates of bacteraemias in the two groups (0.8% vs. 2.7%, respectively, P=0.16). There were 6.87 (95% CI 3.38-14.26) and 16.92 (95% CI 10.61-27.12) colonized AIC and non-AIC catheters, respectively, per 1000 catheter days, a difference that was significant (P<0.01). However, no difference emerged between bacteraemias in AIC and non-AIC catheters per 1000 catheter days measured at 0.98 (95% CI 0.24-5.54) and 3.38 (95% CI 1.29-9.34), respectively (P=0.10). Of the 444 CVCs that were sited in the subclavian or jugular veins and had tips collected, significantly more catheters were colonized in the jugular group, 19 (20%), compared with the subclavian group, 24 (6.9%; P< or =0.01). Overall, the low rates of colonization and bacteraemia may be explained by the population studied, the policies used and the employment of a clinical nurse dedicated to CVC management.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12767841     DOI: 10.1016/s0195-6701(03)00071-9

Source DB:  PubMed          Journal:  J Hosp Infect        ISSN: 0195-6701            Impact factor:   3.926


  7 in total

Review 1.  Anti-infective-treated central venous catheters: a systematic review of randomized controlled trials.

Authors:  B S Niël-Weise; T Stijnen; P J van den Broek
Journal:  Intensive Care Med       Date:  2007-10-17       Impact factor: 17.440

2.  Antimicrobial impregnated catheters in the prevention of catheter-related bloodstream infection in hospitalized patients.

Authors:  Sarah K Wassil; Catherine M Crill; Stephanie J Phelps
Journal:  J Pediatr Pharmacol Ther       Date:  2007-04

Review 3.  APSIC guide for prevention of Central Line Associated Bloodstream Infections (CLABSI).

Authors:  Moi Lin Ling; Anucha Apisarnthanarak; Namita Jaggi; Glenys Harrington; Keita Morikane; Le Thi Anh Thu; Patricia Ching; Victoria Villanueva; Zhiyong Zong; Jae Sim Jeong; Chun-Ming Lee
Journal:  Antimicrob Resist Infect Control       Date:  2016-05-04       Impact factor: 4.887

4.  Strategies to prevent central line-associated bloodstream infections in acute-care hospitals: 2022 Update.

Authors:  Niccolò Buetti; Jonas Marschall; Marci Drees; Mohamad G Fakih; Lynn Hadaway; Lisa L Maragakis; Elizabeth Monsees; Shannon Novosad; Naomi P O'Grady; Mark E Rupp; Joshua Wolf; Deborah Yokoe; Leonard A Mermel
Journal:  Infect Control Hosp Epidemiol       Date:  2022-04-19       Impact factor: 6.520

Review 5.  Access technique and its problems in parenteral nutrition - Guidelines on Parenteral Nutrition, Chapter 9.

Authors:  K W Jauch; W Schregel; Z Stanga; S C Bischoff; P Brass; W Hartl; S Muehlebach; E Pscheidl; P Thul; O Volk
Journal:  Ger Med Sci       Date:  2009-11-18

Review 6.  Catheter impregnation, coating or bonding for reducing central venous catheter-related infections in adults.

Authors:  Nai Ming Lai; Nathorn Chaiyakunapruk; Nai An Lai; Elizabeth O'Riordan; Wilson Shu Cheng Pau; Sanjay Saint
Journal:  Cochrane Database Syst Rev       Date:  2016-03-16

Review 7.  Effectiveness of antimicrobial-coated central venous catheters for preventing catheter-related blood-stream infections with the implementation of bundles: a systematic review and network meta-analysis.

Authors:  Hongliang Wang; Hongshuang Tong; Haitao Liu; Yao Wang; Ruitao Wang; Hong Gao; Pulin Yu; Yanji Lv; Shuangshuang Chen; Guiyue Wang; Miao Liu; Yuhang Li; Kaijiang Yu; Changsong Wang
Journal:  Ann Intensive Care       Date:  2018-06-15       Impact factor: 6.925

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.